(Q39705229)

14 September 2017

title

Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study (English)

1 reference

People's Republic of China

14 September 2017

1 reference

0 references

1 reference

Wei Gong

1

1 reference

14 September 2017

Nonghua Lv

2

1 reference

14 September 2017

Bangmao Wang

3

1 reference

14 September 2017

Ye Chen

4

1 reference

14 September 2017

Yinglong Huang

5

1 reference

14 September 2017

Wenshen Pan

6

1 reference

14 September 2017

Bo Jiang

7

1 reference

14 September 2017

publication date

22 September 2011

1 reference

Digestive Diseases and Sciences

14 September 2017

published in

1 reference

14 September 2017

volume

57

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

503-507

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-011-1890-9

14 September 2017

exact match

0 references

cites work

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Review article: colorectal carcinoma and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Ulcerative colitis and colorectal cancer. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Trends of ulcerative colitis-associated colorectal cancer in Korea: A KASID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Risk of colorectal cancer in ulcerative colitis in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Epidemiology and gene markers of ulcerative colitis in the Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Review article: colitis-associated cancer -- time for new strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1890-9

Classification of inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Diagnosis of colorectal tumorous lesions by magnifying endoscopy

1 reference

12 December 2020

Cancer surveillance in ulcerative colitis. Experience over 15 years

1 reference

12 December 2020

Increased risk of cancer in ulcerative colitis: a population-based cohort study

1 reference

12 December 2020

Cancer risk in extensive ulcerative colitis

1 reference

12 December 2020

10.1007/S10620-011-1890-9

Identifiers

DOI

1 reference

14 September 2017

1 reference